Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The transdermal GFR (tGFR) methodology has ...
Despite recovery of kidney function, kidney transplant recipients have an annual death rate approximately twice as high as the general population, mainly due to cardiovascular disease and ... Measured ...
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
Transdermal GFR System (TGFR) is a first-in-kind product ... More than 800 million people have Chronic Kidney Disease (CKD), one of the world's leading causes of mortality worldwide, with ...
Many older people develop chronic kidney disease and are also likely to be on cholesterol-lowering drugs known as statins.
The transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicity. More than 800 million people have ...
Transdermal GFR System (TGFR ... care assessment of kidney function in patients with normal or impaired renal function More than 800 million people have Chronic Kidney Disease (CKD), one of ...
Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback